-
1.发明公开METHODS AND SYSTEMS FOR PROVIDING THERAPEUTIC GUIDELINES TO A PERSON HAVING DIABETES 审中-公开方法和一种用于提供治疗性准则，患有糖尿病的人
公开(公告)号：EP2539843A2
公开(公告)日：2013-01-02
申请号：EP11714655.5
申请日：2011-02-23
发明人： WAGNER, Robin , WEINERT, Stefan , LAAN, Remmert , WAECHTER, Kurt , REES, Christen , ATKINSON, Craig , SONI, Abhishek , DUKE, David
IPC分类号： G06F19/00
CPC分类号： G06F19/3456 , G06F19/00
摘要： A method is disclosed for providing therapeutic guidelines to a person having diabetes. The method comprises measuring a blood glucose (bG) level of the person for two or more days, wherein at least one bG measurement is taken per day, and the at least one daily bG measurement corresponds to one or more daily events for the person; recording the measured bG levels in a computing device; determining, by the computing device, whether the recorded bG levels are below, within, or above one or more predetermined bG ranges; an automatically providing, by the computing device, therapeutic guidelines to the person, based on whether the recorded bG levels are below, within, or above the one or more predetermined bG ranges.
-
2.发明公开SYSTEM AND METHODS FOR ANALYZING BLOOD GLUCOSE DATA AND QUANTIFYING THE SUCCESS FOR FAILURE OF INSULIN THERAPY 有权系统和方法分析血糖数据和成功的量化拮抗胰岛素治疗失败
公开(公告)号：EP2972378A1
公开(公告)日：2016-01-20
申请号：EP14709648.1
申请日：2014-03-12
CPC分类号： G06F19/3431 , A61B5/14532 , A61B5/4833 , G01N33/66 , G01N2800/042 , G01N2800/52 , G06F19/00 , G16H50/30
摘要： A system and technique are enclosed for determining the effectiveness of a blood glucose therapy treatment. Examples of this technique include analyzing sufficiency of blood glucose data collected from a patient with a computing device, analyzing hypoglycemic risk based on the blood glucose data with the computing device, analyzing glycemic control for the blood glucose data with the computing device, analyzing glycemic variability of the blood glucose data with the computing device, and outputting results from said analyzing the sufficiency, said analyzing the hypoglycemic risk, said analyzing the glycemic control, and said analyzing the glycemic variability with the computing device.
摘要翻译： 的系统和技术被封入用于确定性采矿血糖疗法治疗的有效性。 这种技术的例子包括分析来自与计算设备的患者采集的血糖数据的充分性，基于与所述计算设备的血糖数据分析降糖风险，分析血糖控制为与计算设备的血糖数据，分析血糖变异 与计算设备婷从所述分析的充分导致血糖数据，和输出的，所述分析降糖风险，所述分析的血糖控制，且所述分析与所述计算设备的血糖变异。
-
3.发明公开SYSTEM AND METHOD FOR COLLECTING PATIENT INFORMATION FROM WHICH DIABETES THERAPY MAY BE DETERMINED 有权用于收集患者信息的系统和方法什么糖尿病治疗可确定
公开(公告)号：EP2035989A2
公开(公告)日：2009-03-18
申请号：EP07796156.3
申请日：2007-06-15
发明人： WEINERT, Stefan , BERNINI, Nicole , BRANDT, Derek , ESSENPREIS, Matthias , HEATON, Kelly , JECKELMANN, Joel , LABASTIDE, Sebastiaan , MEYER-OLDEN, Gunnar , SCHOEMAKER, Michael , WAGNER, Robin
IPC分类号： G06F19/00
CPC分类号： G06F19/363 , G06F19/00 , G06F19/3418 , G06F19/3456 , G06F19/3475 , G16H10/20 , G16H10/60 , G16H40/63 , G16H50/20
摘要： A system is provided for collecting patient information from which diabetes therapy may be determined. The system may comprise a patient interface device, a patient notification device, an input device for entering patient information, and an information collecting unit. The information collecting unit may include a processor electrically coupled to a memory having stored therein at least one algorithm executable by the processor to activate the patient notification device followed by presenting instructions to the patient via the patient interface device for collecting specified information from the patient via the input device.
摘要翻译： 一种系统提供了一种用于从其中糖尿病治疗收集患者信息可以是确定的开采。 该系统可以包括一个患者接口装置，患者通知装置到输入装置，用于输入患者信息，以及信息收集单元。 收集单元可以包括电耦合到存储器的处理器的信息具有由所述处理器存储在其中的至少一个算法可执行以激活随后通过患者接口设备呈现指令给患者用于经由从患者收集指定的信息的患者通知装置 输入装置。
-
4.发明公开ADHERENCE INDICATION TOOL FOR CHRONIC DISEASE MANAGEMENT AND METHOD THEREOF 审中-公开仪的慢性病及其方法的治疗依从性DISPLAY
公开(公告)号：EP2446385A2
公开(公告)日：2012-05-02
申请号：EP10730712.6
申请日：2010-06-25
发明人： THUKRAL, Ajay , WEINERT, Stefan , WAGNER, Robin , ZIVITZ, Maury
IPC分类号： G06F19/00
CPC分类号： G06F19/3456 , G06F19/00 , G06F19/325 , G06F19/3475 , G06F19/3481 , G16H50/20
摘要： An adherence indication tool for chronic disease self-management and method thereof for measuring adherence or compliance to following or achieving prescribed therapy steps to achieve stated target goals for improved chronic disease self-management are disclosed.
摘要翻译： 对于慢性疾病的自我管理和方法的粘附指示工具，其用于测量否遵守到处方治疗之后实现或步骤来实现用于改善慢性疾病的自我管理既定目标的目标是游离缺失盘。
-
公开(公告)号：EP1958108A2
公开(公告)日：2008-08-20
申请号：EP06817734.4
申请日：2006-12-04
发明人： WEINERT, Stefan , GALLEY, Paul , THUKRAL, Ajay , CHITTAJALLU, Siva , BUCK, Harvey , WAGNER, Robin , MARCO, Kym , LONG, James, R. , BOUSAMRA, Steven
CPC分类号： G06F19/3456 , G06F9/451 , G06F19/00 , G16H40/63
摘要： A system for determining drug administration information may comprise an input device providing for user input of feed forward information having a first parameter component and a second parameter component, a data storage device and a processor. The data storage device may have stored therein a map correlating values of the first and second parameters to drug administration information. The processor may be responsive to user input of the feed forward information to determine corresponding drug administration information according to the map.
-
公开(公告)号：EP2250597A1
公开(公告)日：2010-11-17
申请号：EP09713757.4
申请日：2009-02-25
CPC分类号： G06Q90/00 , A61B5/14532 , G06F19/00 , G06F19/3456 , G06Q50/24 , G16H10/60 , G16H15/00
摘要： A blood glucose and lifestyle tracking apparatus is disclosed. The blood glucose and lifestyle tracking apparatus provides a method for recording both blood glucose values for fasting, postprandial, and preprandial time periods and lifestyle factors.
-
7.发明公开A SYSTEM AND METHOD PROVIDING FOR USER INTERVENTION IN A DIABETES CONTROL ARRANGEMENT 审中-公开系统和方法，糖尿病控制装置的用户参与
公开(公告)号：EP1891565A1
公开(公告)日：2008-02-27
申请号：EP06754124.3
申请日：2006-06-03
发明人： BOUSAMRA, Steven , CHITTAJALLU, Siva , GALLEY, Paul , THUKRAL, Ajay , WAGNER, Robin , WEINERT, Stefan
CPC分类号： A61M5/172 , A61M5/1723 , A61M2005/14208 , A61M2005/14296 , A61M2205/3569 , A61M2230/201 , G06F19/00 , G06F19/3468 , G16H50/50
摘要： A system providing for user intervention in a medical control arrangement may comprise a first user intervention mechanism responsive to user selection thereof to produce a first user intervention signal, a second user intervention mechanism responsive to user selection thereof to produce a second user intervention signal, and a processor executing a drug delivery algorithm forming part of the medical control arrangement. The processor may be responsive to the first user intervention signal to include an intervention therapy value in the execution of the drug delivery algorithm, and responsive to the second user intervention signal to exclude the intervention therapy value from the execution of the drug delivery algorithm. The medical control arrangement may be a diabetes control arrangement, the drug delivery algorithm may be an insulin delivery algorithm, and the intervention therapy value may be, for example, an intervention insulin quantity or an intervention carbohydrate quantity.
-
-
-
-
-
-
搜索结果
7 条记录 (耗时 0.013 秒)
